Skip to main content

22nd Century Group, Inc. (XXII)

NASDAQ: XXII · IEX Real-Time Price · USD
2.47
0.01 (0.41%)
At close: Dec 8, 2021 4:00 PM
2.49
0.02 (0.81%)
After-hours:Dec 8, 2021 5:47 PM EST
Market Cap401.99M
Revenue (ttm)30.30M
Net Income (ttm)-25.05M
Shares Out162.75M
EPS (ttm)-0.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume942,494
Open2.45
Previous Close2.46
Day's Range2.39 - 2.52
52-Week Range1.78 - 6.07
Beta1.88
AnalystsStrong Buy
Price Target6.33 (+156.3%)
Earnings DateNov 4, 2021

About XXII

22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural...

IndustryTobacco
Founded1998
Employees67
Stock ExchangeNASDAQ
Ticker SymbolXXII
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for XXII stock is "Strong Buy" and the 12-month stock price forecast is 6.33.

Price Target
$6.33
(156.28% upside)
Analyst Consensus: Strong Buy

News

22nd Century Group Announces CFO Transition

BUFFALO, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and im...

2 weeks ago - GlobeNewsWire

22nd Century Group Applauds Califf Nomination as FDA Commissioner

BUFFALO, N.Y., Nov. 15, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and im...

3 weeks ago - GlobeNewsWire

22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021

BUFFALO, N.Y., Nov. 11, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and im...

3 weeks ago - GlobeNewsWire

22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines

Plant-based biotech company 22nd Century Group, Inc. (NASDAQ:XXII) reported its results on Thursday for the third quarter ended September 30, revealing net sales of $7.8 million for the period, up 6.9% ...

1 month ago - Benzinga

22nd Century Group (XXII) Reports Q3 Loss, Lags Revenue Estimates

22nd Century (XXII) delivered earnings and revenue surprises of -50.00% and -2.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021

BUFFALO, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and im...

1 month ago - GlobeNewsWire

Earnings Preview: 22nd Century Group (XXII) Q3 Earnings Expected to Decline

22nd Century (XXII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results

BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and im...

1 month ago - GlobeNewsWire

22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehe...

BUFFALO, N.Y., Oct. 13, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and he...

1 month ago - GlobeNewsWire

Implied Volatility Surging for 22nd Century (XXII) Stock Options

Investors need to pay close attention to 22nd Century (XXII) stock based on the movements in the options market lately.

2 months ago - Zacks Investment Research

22nd Century to Participate in September and October 2021 Investor Conferences

BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness...

2 months ago - GlobeNewsWire

22nd Century Group (Finally) Unveils Its Third Business

The company says the total addressable market across all its businesses is $1.3 trillion.

2 months ago - The Motley Fool

Got $4,000? Buy These 2 Cannabis-Focused Biotech Stocks

Neither of them needs to sell marijuana to consumers to succeed.

Other symbols:JAZZ
3 months ago - The Motley Fool

Why 22nd Century Group Shares Are Trading Lower Today

22nd Century Group Inc (NASDAQ: XXII) is trading lower Monday as investors react to the company's announcement it will enter the specialty hops market. The global specialty hops market will be 22nd Cent...

3 months ago - Benzinga

22nd Century Group Enters Global Specialty Hops Market

Geographic Expansion into Europe via the Netherlands Geographic Expansion into Europe via the Netherlands

3 months ago - GlobeNewsWire

22nd Century Group Announces Franchise In Global Specialty Hops Market

22nd Century Group Inc (NASDAQ:XXII) announced its entry Monday into the global speciality hops market. What Happened: 22nd Century Group is a leading plant biotechnology and intellectual property compa...

3 months ago - Benzinga

22nd Century Group Appoints Accomplished Life Sciences and Biotechnology Executive Anthony Johnson to Board of Directors

Visionary in the Fields of Biotechnology and Genomics to Extend Broad Expertise to Company's Strategy, Technology Development, Commercialization, and Value Creation Efforts

3 months ago - GlobeNewsWire

5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021

Analysts say these are penny stocks to buy. Do you agree?

Other symbols:ACRXJAGXRSLSTELL
3 months ago - PennyStocks

22nd Century to Present at SNN Network Investor Conference on August 19

BUFFALO, N.Y., Aug. 17, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hem...

3 months ago - GlobeNewsWire

3 Cannabis Stocks to Buy and Hold for the Next 10 Years

These companies are securing their future by becoming indispensable to their customers.

Other symbols:GTBIFSMG
3 months ago - The Motley Fool

22nd Century Group to Ring Nasdaq Closing Bell Today, August 16

BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, r...

3 months ago - GlobeNewsWire

3 Under-the-Radar Cannabis Stocks Investors Need to Know

Only focusing on the industry's headliners means you'll miss out on some great opportunities.

Other symbols:CLVRPLNHF
4 months ago - The Motley Fool

22nd Century Group to Begin Trading on Nasdaq on August 16, 2021

BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

4 months ago - GlobeNewsWire

22nd Century Group (XXII) Reports Q2 Loss, Tops Revenue Estimates

22nd Century (XXII) delivered earnings and revenue surprises of 0.00% and 19.59%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021

BUFFALO, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...

4 months ago - GlobeNewsWire